GEVORKYAN Analysis: BUY Rating Confirmed With ~40% Upside and Strong Margin of Safety

By

The company GEVORKYAN, a.s. has, following the recent decline in its share price, entered an interesting situation that may represent an opportunity for the average investor.

The Gafrik Research analysis dated March 30, 2026, confirms a Buy (BUY) recommendation with a target price of 270 CZK (11.01 EUR). At the current price of around 192 CZK, this implies an upside potential of approximately +40%.

It is important, however, to understand that the recent price decline was not caused by a deterioration in the company’s business performance. Instead, it resulted from a technical market event, specifically the issuance of new shares to institutional investors. Through this step, the company raised new capital to support further growth, rather than to address any operational issues.

From a fundamental perspective, the company’s investment case remains unchanged:

  • revenues are growing at a double-digit rate,
  • the company achieves above-average profitability within its industry,
  • and it benefits from high visibility of future revenues thanks to long-term contracts.

In simple terms: the market is currently valuing the company significantly lower than its actual performance and long-term potential would suggest.

For investors, this creates a situation where:

  • potential upside is significant,
  • downside risk appears limited according to the analysis,
  • and the current price level has already been utilized by institutional investors as an entry point.

This report is published as issuer-sponsored research, prepared with full editorial independence in accordance with the Gafrik Research Analytical Methodology. All conclusions are based solely on independent analysis.

The full Initiating Quarter Report is available via Refinitiv and below.

[DOWNLOAD FULL REPORT PDF] (click right, save as)

Important Notice: This post is a summary of the full research report. It is provided for informational purposes only and does not constitute investment advice. Gafrik Research was compensated by the issuer for the preparation of this report, but maintains full editorial independence. For the full list of disclosures, rating definitions, and analyst certifications, please refer to the complete PDF report available for download above.